Mathini Ilancheran
ARTICLES BY MATHINI ILANCHERAN
-
Global Implications Of Zero Tariffs On Indian Pharma Exports To China11/5/2025
Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
-
Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development10/21/2025
Discover how partnerships — especially with capable CROs — as well as resilient supply chains, digital enablement, regulatory foresight, and specialized talent impact the success of targeted protein degradation therapies.
-
100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing10/17/2025
Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.
-
The Effects Of Most Favored Nation Drug Pricing On Clinical Trial Management6/24/2025
Market expert Mathini Ilancheran explains how sponsors can mitigate the effects of "Most Favored Nation" drug pricing while maintaining trial integrity and accelerating time to market.
-
Global AI In Clinical Trials: Market Trends & Current Partnerships2/24/2025
Discover the global market for AI in clinical research — from growth and potential to current use cases to new partnerships.
-
An Overview Of Patient Service Programs Technology12/15/2023
Discover all the applicable technologies aimed at improving patient adherence, patient access, patient affordability, and patient advocacy.
-
India's New Drugs, Medical Devices, And Cosmetics Draft Bill 202211/7/2022
To accommodate changing requirements and encourage the adoption of new technology, India’s Ministry of Health and Family Welfare released a draft bill in July 2022 to replace the existing Drugs and Cosmetics Act 1940. What are the major areas of change and how much of an impact will there be?
-
The Supply & Demand For Clinical Trial Staffing In 2022 & Beyond5/5/2022
The clinical trial staffing market is a high-margin market due to increasing numbers of clinical trials globally and high demand for resources. With the ongoing shortage of CRAs and those in other clinical operations roles, it is important for pharma companies to understand the current trends and how technology providers can help you tackle the attrition problem and manage the growing demand.
-
Trends In Decentralized Clinical Trial Remote Monitoring For Medication Adherence2/23/2022
With the implementation of real-time remote monitoring technology, pharmas will be able to do more remote studies that require clinical trial patients to visit sites less frequently. This will remove the burden on patients and improve patient recruitment and retention. This article focuses on the patient medication adherence market.
-
Use Of Wearable And Sensor Applications In Clinical Trials Is Booming10/26/2021
Experts predict 50% of clinical trials will incorporate wearables and sensors by 2025, compared to the 10 to 15% at present. This article shares market research on the use of wearables and sensors in clinical trials, including smartwatches, ingestible sensor-embedded pills, and more.